QUICK POLL
Although recent data suggests no preventive cancer benefit from anti-oxidants, a recently reported randomized trial suggested that high intake of folic acid, vitamin B6, and vitamin B12 may significantly reduce breast and other forms of cancer in women.
11th International Symposium on Febrile Neutropenia
20 - 21 February 2009
Valencia, Spain
The Westin Valencia
Who Should Attend
This educational activity is designed for medical oncologists, infectious disease specialists, and other physicians, physicians-in-training, and healthcare professionals interested and/or involved in the care of patients with febrile neutropenia.
Objectives
After successful completion of this educational activity, participants should be able to:
- Discuss and evaluate pharmacological options for the administration of antifungal agents in febrile neutropenic patients
- Identify and assess intensive care management strategies for critical complications of febrile neutropenia, such as pneumonia and septic shock
- Describe the pathogenesis, implications, challenges and opportunities surrounding severe immunodepression in febrile neutropenic patients
- Discuss pediatric issues of febrile neutropenia, and propose treatment regimens to appropriately manage this specific patient population
- Compare current and emerging therapies in the prevention and management of febrile neutropenic patients
David R. Andes, MD
University of Wisconsin School of Medicine
Madison, Wisconsin, United States
Élie Azoulay, MD, PhD
Saint-Louis University Hospital
Paris, France
Dominique Benoit, MD, PhD
Ghent University Hospital
Ghent, Belgium
Rafael de la Camara, MD
Hospital de la Princesa
Madrid, Spain
J. Peter Donnelly, PhD
University Medical Center St. Radboud
Nijmegen, The Netherlands
Marta González-Vicent, MD
Niño Jesús Children’s Hospital
Madrid, Spain
Gilles Hilbert, MD
University Hospital
Bordeaux, France
William Hope, MBBS, FRACP, FRCPA, PhD
The University of Manchester School of Medicine
Manchester, United Kingdom
Elizabeth M. Johnson, PhD
South West HPA Laboratory
Bristol, United Kingdom
Jean A. Klastersky, MD, PhD
Jules Bordet Institute
Brussels, Belgium
Vicki A. Morrison, MD
The University of Minnesota Medical School
Minneapolis, Minnesota, United States
Hulya Ozsahin, MD
Geneva University Hospital
Geneva, Switzerland
Maria Elena Santolaya, MD
Chilean Society of Infection
Santiago, Chile
Miguel A. Sanz, MD, PhD
University Hospital La Fe
Valencia, Spain
John R. Wingard, MD
University of Florida Shands Cancer Center
Gainesville, Florida, United States
Friday, 20 February 2009
8:00 Introduction
Jean A. Klastersky, MD, PhD
Session I: Pharmacological Considerations for the Administration of Antifungal Agents
Chair: J. Peter Donnelly, PhD
Co-Chair: Elizabeth M. Johnson, PhD
8:10 State-of-the art lecture: Efficacy is a matter of fact; pharmacology, a matter of opinion
David R. Andes, MD
8:55 Discussion
9:10 Break
9:30 Oral abstracts
10:20 Case presentation
William Hope, MBBS, FRACP, FRCPA, PhD
11:10 Session chairs‘ summary
J. Peter Donnelly, PhD
Elizabeth M. Johnson, PhD
11:15 Lunch
Session II: Intensive Care for Patients with Febrile Neutropenia
Chair: Jean A. Klastersky, MD, PhD
Co-Chair: Gilles Hilbert, MD
13:30 State-of-the art lecture: Indications and achievements of intensive care in febrile neutropenic patients
Élie Azoulay, MD, PhD
14:15 Discussion
14:30 Break
14:50 Oral abstracts
15:40 Case presentation
Dominique Benoit, MD
16:30 Session chairs’ summary
Jean A. Klastersky, MD, PhD
Gilles Hilbert, MD
16:40 Adjourn
Saturday, 21 February 2009
8:00 Welcome and introduction to day two
Miguel A. Sanz, MD, PhD
Session III: Severe Immunodepression Complicating Febrile Neutropenia
Chair: John R. Wingard, MD
Co-Chair: Rafael de la Camara, MD
8:10 State-of–the art lecture: The infectious challenge beyond neutropenia: New drugs and new bugs
Vickie A. Morrison, MD
8:55 Discussion
9:10 Break
9:30 Oral abstracts
10:20 Case presentation
Rafael de la Camara, MD
11:10 Session chairs’ summary
John R. Wingard, MD
Rafael de la Camara, MD
11:15 Lunch
Session IV: Specific Pediatric Aspects of Febrile Neutropenia
Chair: Miguel A. Sanz, MD, PhD
Co-Chair: Hulya Ozsahin, MD
13:30 State-of-the art lecture: Sepsis and mortality related with febrile neutropenia in children with cancer
Maria Elena Santolaya, MD
14:15 Discussion
14:30 Break
14:50 Oral abstracts
15:40 Case presentation
Marta González-Vicent, MD
16:30 Session chairs’ summary
Miguel A. Sanz, MD, PhD
Hulya Ozsahin, MD
16:40 Adjourn with summary by chair and local chair
Jean A. Klastersky, MD, PhD
Miguel A. Sanz, MD, PhD
Submission Deadline: 22 December 2008
Participants interested in presenting data should submit abstracts online at www.imedex.com by 22 December 2008. Abstracts are subject to acceptance by the Scientific Committee. Once accepted, abstracts will be published in the final Symposiumbook and scheduled for oral or poster presentation.
Acceptance notifications and guidelines for poster presentation will be sent on 14 January 2009. Authors of accepted abstracts who have not registered will have until 10 February 2009 to do so at the rate of €550. After this date, abstracts without registered presenters will be disregarded.
Abstract Guidelines
- Follow the online instructions
- Abstracts must be written in English
- Accepted format: Word document format (.DOC), 9 point Arial font, 500 word count limit
- Use a concise title
- List affiliations of author(s) as briefly as possible, with city, state and country
- Place an asterisk (*) before the name of the presenting author
- Use standard and well-accepted abbreviations
- When using references, use standard and well-accepted formats
- Abstract content should be single-spaced, typed in lower case and contain: purpose of the study, summarized description of the project, and results and conclusions
Registration Fees
Discounted € 550
If payment received by 22 December 2008
Regular € 625
If payment received by 10 February 2009
Full € 695
If payment received after 10 February 2009
Nurses/Residents/Students* € 200
*Proof of eligibility must accompany registration
Registration Procedure
You may register online by 10 February 2009 or by calling Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the symposium.
To pre-register, registration and payment must be received no later than 10 February 2009. Please register onsite after this date.
Registration and Information Desk Hours
The Registration and Information Desk will be staffed:
Friday, 20 February 2009 . . . . . . . . . . .7:00 – 16:40
Saturday, 21 February 2009 . . . . . . . . .7:30 – 16:40
Payment
Registration fees must be remitted by credit card, check, or wire transfer. Checks should be payable to Imedex. To pay via wire transfer, you must add €50 to each wire transaction to cover bank charges. Include the full name of the attendee and the name of the symposium: 11th International Symposium on Febrile Neutropenia A057.01. An attendee is not registered until full payment is received.
Wire Transfer Information
Bank of America, NA London, 1 Alie Street E1ADE London UK
Swift Code: BOFAGB22
Sort Code: 165050
Beneficiary: Bank of America Domestic Deposit #5687
Account #: 600895687029
Reference: Imedex, Inc. Account # 10726-118
IBAN: GB89 BOFA 1650 5095 6870 29
Registration Fee Inclusions
Registration fees include admittance to all scientific sessions, symposium materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the program.
Cancellation
For registration fees to be refunded, written notice of cancellation must be received at Imedex no later than 10 February 2009. The amount of registration fees remitted, minus a €90 administrative charge, will be refunded after the symposium. Substitutions are accepted with written notification. No refunds will be made if notice is received after 10 February 2009.
Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this symposium should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.
Amadeo de Saboya 16
46010 Valencia, Espana
Tel.: +34 963 625 900
Fax: +34 963 625 909
http://www.starwoodhotels.com
The Westin Valencia is now one of the most impressive structures in the city of Valencia. The building was originally constructed in a modernist style dating from 1917. Situated within walking distance from the historical, cultural, and shopping center of Valencia, it is the perfect location for discovering the city.
35 guest rooms combine a classic style with avant-garde technology, complete with the exclusive Westin Heavenly Bed®, Westin Heavenly Bath, and High Speed Internet Access. Five ultramodern meeting rooms and one banquet room make the hotel ideal for meetings and conferences.
For the convenience of attendees, a limited number of rooms have been reserved until 29 January, 2009 at a discounted rate of €194 single/double occupancy, plus tax, currently at 7% VAT. This rate is not guaranteed outside the symposium dates or after 29 January 2009.
To reserve your room please contact the Westin Valencia reservations department at +34 963 625 900 or visit http://www.starwoodmeeting.com/StarGroupsWeb/res?id=0811059814&key=4A4BF. To receive the group rate, callers must identify themselves as being with the 11th International Symposium on Febrile Neutropenia group. Reservation requests received after 29 January 2009 may not be guaranteed the group rate.
Dear Colleagues,
It is with great pleasure that we invite you to join us in Valencia, Spain this February for the 11th International Symposium on Febrile Neutropenia. Previous attendees have had high praise for the quality of the scientific program and the exceptional international faculty and they have stated that participation in this symposium significantly enhanced their knowledge of the implications and management of febrile neutropenia.
The unique presentation format of the International Symposium on Febrile Neutropenia features four sessions, each of which features a state of the art lecture, case presentation, oral abstract presentations and a summary by the session chair. Ultimately, attendees will have a thorough overview of the latest research and clinical applications of each topic.
Presentation of new and exciting research is a hallmark of this meeting. We invite you to participate this year by submitting an abstract of your work to be considered for presentation.
Management of febrile neutropenic patients requires careful assessment and treatment. The cutting-edge scientific data and clinically relevant information you will receive at the International Symposium on Febrile Neutropenia will provide an immediate impact on your clinical practice or research efforts.
The beautiful and vibrant city of Valencia will provide a perfect backdrop for what promises to be an exceptional educational event. We hope you will plan to join us!
Sincerely,
Chair
Jean A. Klastersky, MD, PhD
Local Chair
Miguel A. Sanz, MD, PhD
ORGANIZER
Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Important Dates
Abstract Submission Deadline
22 December 2008
Discounted Registration Deadline
22 December 2008
Abstract Notifications Mailed
14 January 2009
Abstract Presenter Registration Deadline
10 February 2009
Regular Registration Deadline
10 February 2009
Presentation Dates
20 – 21 February 2009
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2008 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
The following company has provided an unrestricted educational grant in support of this symposium:
PLATINUM |
Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.